Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neopterin on Admission to the ICU: an Immunological Biomarker That Could Help Admission Decisions by Identifying Elderly Patients (≥80 Years) Able to Survive an ICU Stay Without Disability

NCT05233267 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT05233267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05233267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neopterin on Admission to the ICU: an Immunological Biomarker That Could Help Admission Decisions by Identifying Elderly Patients (≥80 Years) Able to Survive an ICU Stay Without Disability
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Active, not recruiting
Start date
November 21, 2022
Completion date
September 30, 2026
Enrollment
313 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly patient (80 years old or more) admitted to intensive care